DD273974A5 - Verfahren zur herstellung von diaeterzeugnissen - Google Patents
Verfahren zur herstellung von diaeterzeugnissen Download PDFInfo
- Publication number
- DD273974A5 DD273974A5 DD88313813A DD31381388A DD273974A5 DD 273974 A5 DD273974 A5 DD 273974A5 DD 88313813 A DD88313813 A DD 88313813A DD 31381388 A DD31381388 A DD 31381388A DD 273974 A5 DD273974 A5 DD 273974A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- fatty acids
- algae
- selenium
- epa
- dha
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title abstract description 12
- 239000012502 diagnostic product Substances 0.000 title 1
- 239000011669 selenium Substances 0.000 claims abstract description 44
- 241000195493 Cryptophyta Species 0.000 claims abstract description 43
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 36
- 230000008569 process Effects 0.000 claims abstract description 20
- 239000000194 fatty acid Substances 0.000 claims abstract description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 4
- -1 fatty acid esters Chemical class 0.000 claims description 11
- 241000251468 Actinopterygii Species 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims 1
- 235000005911 diet Nutrition 0.000 abstract description 22
- 230000000378 dietary effect Effects 0.000 abstract description 20
- 230000002265 prevention Effects 0.000 abstract description 6
- 206010003645 Atopy Diseases 0.000 abstract description 4
- 206010061216 Infarction Diseases 0.000 abstract description 4
- 230000007574 infarction Effects 0.000 abstract description 4
- 208000012657 Atopic disease Diseases 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 210000000748 cardiovascular system Anatomy 0.000 abstract description 3
- 230000000740 bleeding effect Effects 0.000 abstract description 2
- 230000009424 thromboembolic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 36
- 229940091258 selenium supplement Drugs 0.000 description 34
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 31
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 30
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 30
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 28
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000003026 cod liver oil Substances 0.000 description 10
- 235000012716 cod liver oil Nutrition 0.000 description 10
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 8
- 230000002349 favourable effect Effects 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229930003427 Vitamin E Natural products 0.000 description 7
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical group CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 7
- 235000019688 fish Nutrition 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 235000019165 vitamin E Nutrition 0.000 description 7
- 239000011709 vitamin E Substances 0.000 description 7
- 229940046009 vitamin E Drugs 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 235000013310 margarine Nutrition 0.000 description 6
- 239000003264 margarine Substances 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 150000004671 saturated fatty acids Chemical class 0.000 description 6
- 235000003441 saturated fatty acids Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 230000009965 odorless effect Effects 0.000 description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 4
- 229940012843 omega-3 fatty acid Drugs 0.000 description 4
- 239000006014 omega-3 oil Substances 0.000 description 4
- 238000005502 peroxidation Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 241000276438 Gadus morhua Species 0.000 description 3
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 3
- 241001125048 Sardina Species 0.000 description 3
- 241000195663 Scenedesmus Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229940118019 malondialdehyde Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 201000002772 Kwashiorkor Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000003851 biochemical process Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000019516 cod Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 210000003617 erythrocyte membrane Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000010686 shark liver oil Substances 0.000 description 2
- 229940069764 shark liver oil Drugs 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010028320 muscle necrosis Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/001—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU871174A HU202088B (en) | 1987-03-18 | 1987-03-18 | Method for producing dietetic preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD273974A5 true DD273974A5 (de) | 1989-12-06 |
Family
ID=10953177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88313813A DD273974A5 (de) | 1987-03-18 | 1988-03-18 | Verfahren zur herstellung von diaeterzeugnissen |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS642551A (fr) |
| BE (1) | BE1002429A3 (fr) |
| CH (1) | CH677863A5 (fr) |
| DD (1) | DD273974A5 (fr) |
| DE (1) | DE3809238A1 (fr) |
| ES (1) | ES2009248A6 (fr) |
| FI (1) | FI881308A (fr) |
| FR (1) | FR2612373B1 (fr) |
| GB (1) | GB2203043A (fr) |
| HU (1) | HU202088B (fr) |
| IT (1) | IT1216139B (fr) |
| LU (1) | LU87170A1 (fr) |
| NL (1) | NL8800691A (fr) |
| SE (1) | SE468785B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU210122B (en) * | 1988-03-23 | 1995-02-28 | Biorex Kutato Fejlesztoe Kft | Process for production of composition against thromboembolytic conditions of circulating system and heart |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| DK162621C (da) * | 1989-04-27 | 1992-04-13 | Jon Katborg | Skumformigt fedtstofprodukt og fremgangsmaade til fremstilling af samme |
| JP2525236Y2 (ja) * | 1989-09-27 | 1997-02-05 | 株式会社アテックス | 歩行型移動農機のハンドル位置調節装置 |
| ATE147592T1 (de) * | 1990-02-05 | 1997-02-15 | Lifescience Corp | Vitamine und mineralien enthaltende nahrungszusätze |
| DE19629433A1 (de) * | 1996-07-22 | 1998-01-29 | Hoechst Ag | Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier |
| GB2363331B (en) * | 2000-06-17 | 2003-02-05 | Raymond Clifford Noble | Supplement to enhance fertility |
| US7416752B2 (en) | 2004-01-06 | 2008-08-26 | Sharp Ingrained Functional Foods, Inc. | Method of fortifying seeds with an essential fatty acid, fortified seed and food product |
| DE102006021478A1 (de) * | 2006-05-09 | 2007-11-15 | Tilco Biochemie Gmbh | Präparat zur Körperbehandlung |
| DE102017130419A1 (de) | 2017-07-05 | 2019-01-10 | Richard Kuntzsch | Nahrungsergänzungsmittel auf Schokoladenbasis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1057844A (fr) * | 1951-06-14 | 1954-03-11 | Procédé pour l'obtention de produits destinés à remédier aux ?ences alimentaires en oligo-éléments | |
| JPS5545303A (en) * | 1978-09-25 | 1980-03-31 | Yoshio Tanaka | Preparation of health food and its device |
| FR2479657A1 (fr) * | 1980-04-03 | 1981-10-09 | Le Trividic Noemie | Procede de preparation d'aliments a base de poissons et d'algues |
| GB2098065A (en) * | 1981-04-14 | 1982-11-17 | Nippon Suisan Kaisha Ltd | Antithrombotic compositions containing docosahexaenoic acid |
| FR2547829B1 (fr) * | 1983-05-28 | 1988-11-18 | Sekimoto Hiroshi | Compositions contenant des composes d'acides gras insatures et procede de stabilisation de tels composes |
| DE3421644A1 (de) * | 1984-06-09 | 1985-12-12 | Richard 7880 Bad Säckingen Hau | Diaetetische zusammensetzung |
| FR2569536A1 (fr) * | 1984-08-30 | 1986-03-07 | Michel Maillols | Nutriments biologiques |
-
1987
- 1987-03-18 HU HU871174A patent/HU202088B/hu not_active IP Right Cessation
-
1988
- 1988-03-17 CH CH1008/88A patent/CH677863A5/de not_active IP Right Cessation
- 1988-03-18 NL NL8800691A patent/NL8800691A/nl not_active Application Discontinuation
- 1988-03-18 IT IT8819835A patent/IT1216139B/it active
- 1988-03-18 SE SE8800989A patent/SE468785B/sv not_active Application Discontinuation
- 1988-03-18 JP JP63063749A patent/JPS642551A/ja active Pending
- 1988-03-18 LU LU87170A patent/LU87170A1/fr unknown
- 1988-03-18 DE DE3809238A patent/DE3809238A1/de not_active Withdrawn
- 1988-03-18 BE BE8800308A patent/BE1002429A3/fr not_active IP Right Cessation
- 1988-03-18 FI FI881308A patent/FI881308A/fi not_active Application Discontinuation
- 1988-03-18 ES ES8800826A patent/ES2009248A6/es not_active Expired
- 1988-03-18 FR FR888803514A patent/FR2612373B1/fr not_active Expired - Fee Related
- 1988-03-18 GB GB08806531A patent/GB2203043A/en not_active Withdrawn
- 1988-03-18 DD DD88313813A patent/DD273974A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE8800989D0 (sv) | 1988-03-18 |
| FI881308A0 (fi) | 1988-03-18 |
| HUT45873A (en) | 1988-09-28 |
| IT8819835A0 (it) | 1988-03-18 |
| IT1216139B (it) | 1990-02-22 |
| NL8800691A (nl) | 1988-10-17 |
| GB8806531D0 (en) | 1988-04-20 |
| BE1002429A3 (fr) | 1991-02-05 |
| SE8800989L (sv) | 1988-09-19 |
| ES2009248A6 (es) | 1989-09-16 |
| LU87170A1 (fr) | 1989-10-26 |
| CH677863A5 (fr) | 1991-07-15 |
| HU202088B (en) | 1991-02-28 |
| FI881308A (fi) | 1988-09-19 |
| JPS642551A (en) | 1989-01-06 |
| GB2203043A (en) | 1988-10-12 |
| SE468785B (sv) | 1993-03-22 |
| FR2612373B1 (fr) | 1991-04-05 |
| FR2612373A1 (fr) | 1988-09-23 |
| DE3809238A1 (de) | 1988-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69129296T3 (de) | Docosahexaensäure, verfahren zu ihrer herstellung und sie enthaltende verbindungen | |
| DE60208544T2 (de) | Natürliche phenolische produkte und deren derivate zum schutz vor neurodegenerativen erkrankungen | |
| DE3138088C2 (fr) | ||
| DE69910152T2 (de) | Verwendung von Phytosterol und/oder Phytostanolestern | |
| DE69824501T2 (de) | Fettenthaltende Nahrungsmittelprodukte mit Sterolen | |
| DE69233556T2 (de) | Arachidonsäure und Verfahren zu ihrer Herstellung sowie Verwendung derselben | |
| DE3920679C2 (fr) | ||
| DE69609196T3 (de) | Verfahren zur Herstellung von Materialien mit hohem Gehalt an isomeren von konjugierter Linolsäure | |
| DE69433713T2 (de) | Für die behandlung neurologischer erkrankungen nützliche methoden und pharmazeutische zusammensetzungen | |
| DE60306781T2 (de) | Naturstoffe und deren derivate zur prävention und behandlung von herzkreislauf-, leber- und nierenerkrankungen und für kosmetische anwendungen | |
| DE69630195T2 (de) | Verwendung eines ausgleichenden zusatzstoffes für omega-6 und omega-3 ungesättigte fettsäure | |
| DE69722210T2 (de) | Verfahren zur herstellung einer mischung von sterin-estern | |
| DE3438630A1 (de) | Kombinierte fettsaeurezusammensetzung zur senkung des cholesterin- und triglycerid-blutspiegels | |
| NZ203828A (en) | Extracting fatty substances from the pips of fruit of the ribes genus | |
| DE102005003625A1 (de) | Verfahren zur Herstellung einer DHA-haltigen Fettsäure-Zusammensetzung | |
| EP0231904A2 (fr) | Mélange gras riche en acides polyéniques et son utilisation dans la préparation d'aliments pour nourrissons | |
| DE3151245A1 (de) | Zur enteralen ernaehrung geeignete nahrungszusammensetzung | |
| DE3909707A1 (de) | Arzneimittel, geeignet zur einwirkung auf herz und kreislauf | |
| DD273974A5 (de) | Verfahren zur herstellung von diaeterzeugnissen | |
| DE60132523T2 (de) | Pharmazeutische- und Nahrungsmittelzusammensetzungen mit "Holzalkohol" und "Holzsterol" zur Senkung des Serumcholesterins | |
| EP0584159B1 (fr) | Preparation de substances nutritives | |
| AT395818B (de) | Auf das herz-kreislauf-system wirkende arzneimittelpraeparate und verfahren zur herstellung derselben | |
| DE69523759T3 (de) | Zubereitungen der nervonsäure | |
| US5336792A (en) | Process for enrichment of fat with regard to polyunsaturated fatty acids and phospholipids, and application of such enriched fat | |
| JPH012551A (ja) | 食餌性組成物およびその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |